- Report
- June 2023
- 338 Pages
Global
From €7284EUR$7,500USD£6,284GBP
- Report
- January 2020
- 473 Pages
Global
From €4758EUR$4,899USD£4,105GBP
Travatan Z is a medication used to treat glaucoma and ocular hypertension, two common optical disorders. It is a prostaglandin analog, a type of drug that works by decreasing the amount of fluid in the eye, thereby reducing intraocular pressure. It is available in both eye drop and implant form, and is typically used in combination with other medications. Travatan Z is generally well-tolerated, with the most common side effects being eye irritation, redness, and blurred vision.
The Travatan Z market is a subset of the larger optical disorders drugs market, which includes medications used to treat a variety of eye conditions. This market is highly competitive, with a number of companies offering similar products. Some of the major players in the Travatan Z market include Allergan, Bausch + Lomb, and Santen Pharmaceuticals. Show Less Read more